Making Treatment Decisions in Myeloma: How Do I Know What’s Right for Me?

Published on

Topics include: Treatment

The landscape of myeloma care is constantly evolving with the development of new research and treatment. While advances in myeloma therapies are exciting and beneficial, some patients feel overwhelmed making treatment decisions between all the available options. Myeloma patient Jack Aiello leads a discussion with Dr. Robert Orlowski of The University of Texas MD Anderson Cancer Center and Dr. Noopur Raje of Massachusetts General Hospital Cancer Center as they help decipher which type of therapy is appropriate for different conditions. They also consider the role of a transplant amidst new medicines, and the impact they have on attaining minimal residual disease (MRD) or complete remission.

Produced by Patient Power in partnership with The University of Texas MD Anderson Cancer Center. We thank AbbVie Inc. and Takeda Oncology for their support.

View more programs featuring , and

Produced in association with

Related Programs

Why Should Patients Avoid Antioxidants When Receiving Certain Myeloma Treatments?

Patient Power community member, Paula, wants to know why some patients on multiple myeloma maintenance therapy are are advised to avoid antioxidants. Dr. Jatin Shah responds.


Myeloma Treatment: Where Does Immunotherapy Fit In?

Dr. Frits van Rhee from the UAMS Myeloma Institute explains various immunotherapies—both current and in development—for multiple myeloma patients.


How Do the Latest Myeloma Treatment Approvals Affect Newly Diagnosed Patients?

From our multiple myeloma roundtable at 2015 American Society of Hematology (ASH) meeting, Drs. John Burke and Faith Davies along with patient advocate Jack Aiello discuss the latest treatments that affect newly diagnosed patients.


Join Our Community Register for Events Read Our Latest Blog

Page last updated on December 22, 2017